Condition
Brain Tumor, Recurrent clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Brain Tumor, Recurrent clinical trials that are recruiting, at sites in 2 countries (most in United States (5), Taiwan (1)). By phase: Phase 1 (3), Phase 2 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 2Countries
Newest Brain Tumor, Recurrent clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Neuro-navigation-guided focused ultrasound with nivolumab for relapsed or progressive high-grade brain tumors in children | Phase 1 | Washington D.C., District of Columbia | Recruiting | Jun 24, 2026 |
| B7-H3 CAR T cells for recurrent brain tumors in kids and young adults | Phase 1 | Boston, Massachusetts and 1 other locations | Recruiting | Feb 5, 2026 |
| Chronic convection-enhanced delivery of topotecan for recurrent IDH‑mutant malignant glioma | Phase 1 | New York, New York | Recruiting | Oct 31, 2024 |
| Evaluating Bevacizumab with Focused Ultrasound for Recurrent Glioblastoma | Phase 3 | Taipei and 1 other locations | Recruiting | Jul 11, 2024 |
| Registry of patients with brain tumors treated with GammaTiles | — | Phoenix, Arizona and 53 other locations | Recruiting | Jun 11, 2020 |
| Targeting brain tumors with a specific drug infusion and re-irradiation | Phase 2 | New York, New York | Recruiting | Jun 15, 2016 |
All recruiting trials (6)
-
Neuro-navigation-guided focused ultrasound with nivolumab for relapsed or progressive high-grade brain tumors in children
This study tests whether using focused ultrasound to open the blood-brain barrier and give nivolumab is safe and feasible for kids with relapsed or progressive DMG/DIPG or other high-grade brain tumors.
-
B7-H3 CAR T cells for recurrent brain tumors in kids and young adults
This early-phase trial tests a personalized CAR T-cell therapy called B7-H3 CAR T for children and young adults with recurrent or progressive brain tumors.
-
Chronic convection-enhanced delivery of topotecan for recurrent IDH‑mutant malignant glioma
This trial will try giving the chemotherapy drug topotecan directly into the brain with an implanted pump for adults with recurrent IDH‑mutant malignant glioma to see if it is safe and reaches the tumor.
-
Evaluating Bevacizumab with Focused Ultrasound for Recurrent Glioblastoma
This study is testing if adding focused ultrasound to the standard treatment of Bevacizumab can help people with recurrent glioblastoma feel better and live longer.
-
Registry of patients with brain tumors treated with GammaTiles
This study is testing how well GammaTiles treatment works for people with brain tumors after surgery, looking at their health and quality of life over five years.
-
Targeting brain tumors with a specific drug infusion and re-irradiation
This study is testing a new way to deliver a drug directly to brain tumors in patients with certain aggressive types of glioblastoma to see if it can improve treatment results.
Related topics
Quick answers
How many Brain Tumor, Recurrent clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (5 trials), Taiwan (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 3, Phase 2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.